2,3-piperidinedicarboxylic acid has been researched along with Night Blindness in 2 studies
2,3-piperidinedicarboxylic acid: effective antagonist at all three types of excitatory amino acid receptors; does not depress responses to acetylcholine or substance P
Night Blindness: Failure or imperfection of vision at night or in dim light, with good vision only on bright days. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, NW | 1 |
| Kondo, M | 1 |
| Hiriyanna, KT | 1 |
| Jamison, JA | 1 |
| Bush, RA | 1 |
| Sieving, PA | 1 |
| Shirato, S | 1 |
| Maeda, H | 1 |
| Miura, G | 1 |
| Frishman, LJ | 1 |
2 other studies available for 2,3-piperidinedicarboxylic acid and Night Blindness
| Article | Year |
|---|---|
Primate Retinal Signaling Pathways: Suppressing ON-Pathway Activity in Monkey With Glutamate Analogues Mimics Human CSNB1-NYX Genetic Night Blindness.
Topics: Adolescent; Adult; Aminobutyrates; Animals; DNA Mutational Analysis; Dose-Response Relationship, Rad | 2005 |
Postreceptoral contributions to the light-adapted ERG of mice lacking b-waves.
Topics: Adaptation, Ocular; Aging; Aminobutyrates; Animals; Disease Models, Animal; Electroretinography; Mal | 2008 |